Ramakrishna Rao, MD
Psychiatry · San Antonio, TXNPI 1457397903
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 10.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $561, more than ten times the $27 reported in 2021.
Across 50 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$102
- E.r. Squibb & Sons, L.L.C.$95
- Validus Pharmaceuticals LLC$83
- AbbVie$76
- Corium, LLC$75
- Axsome Therapeutics, Inc.$68
- plus $480 from 12 others
What the payments were for
- Food & beverage$95197%
- Education$273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $102 |
| E.r. Squibb & Sons, L.L.C. | 4 | $95 |
| Validus Pharmaceuticals LLC | 4 | $83 |
| AbbVie | 5 | $76 |
| Corium, LLC | 5 | $75 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Almatica Pharma LLC | 3 | $53 |
| Lundbeck LLC | 3 | $52 |
| Alkermes, Inc. | 3 | $49 |
| Johnson & Johnson | 2 | $48 |
| Idorsia Pharmaceuticals US Inc | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| Noven Therapeutics, LLC | 2 | $45 |
| Tris Pharma Inc | 2 | $40 |
| Ironshore Pharmaceuticals Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Bausch Health US, LLC | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
How this compares
$978 in reported general payments places this provider in the 70th percentile of 2,238 psychiatry providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in San Antonio
- Thomas WeissSan Antonio$744K
- Nathan JohnstonSan Antonio$435K
- Damaso OlivaSan Antonio$170K
- Edmund WilliamsSan Antonio$142K
- Jair SoaresSan Antonio$69K
- James RedmondSan Antonio$42K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.